| NEK2 expression based on | ||||||||||||||||||||||||||
GBM : Glioblastoma multiforme*
Please note that low number(<10) of normal samples considered.
| ||||||||||||||||||||||||||
GBM : Glioblastoma multiforme*
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 2 samples.
| ||||||||||||||||||||||||||
GBM : Glioblastoma multiforme*
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
| ||||||||||||||||||||||||||
GBM : Glioblastoma multiforme*
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
| ||||||||||||||||||||||||||
GBM : Glioblastoma multiforme*
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 4 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
| ||||||||||||||||||||||||||